Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

4,520 results
Display

Intra-individual comparison of two-dimensional shear wave elastography techniques using plane wave imaging and the multi-beam technique: are they interchangeable in measuring liver fibrosis?

Kim JH, Yoon JH, Joo I, Lee JM

Purpose: This study compared two different two-dimensional shear wave elastography techniques—plane wave imaging (PWI) and multi-beam (MB) imaging—from the same vendor to evaluate liver fibrosis. Methods: In this prospective study, 42...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?

Seo DM, Lee SM, Park JW, Kim MJ, Ha HI, Park SY, Lee K

Purpose: This retrospective study aimed to determine the number of times the ultrasound-guided attenuation parameter (UGAP) should be measured during the evaluation of hepatic steatosis. Methods: Patients with suspected nonalcoholic fatty...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adult hepatoblastoma: making the challenging distinction from hepatocellular carcinoma

Pagarigan AKL, Mendoza PGL

Hepatoblastoma is an exceptionally rare malignancy in adults with just over 70 non-pediatric cases reported in literature. Recounted is a case of a 49-year-old female who presented with acute right...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Defining the optimal technique for endoscopic ultrasound shear wave elastography: a combined benchtop and animal model study with comparison to transabdominal shear wave elastography

Wang TJ, Ryou M

Background/Aims: Shear wave elastography (SWE) is used for liver fibrosis staging based on stiffness measurements. It can be performed using endoscopic ultrasound (EUS) or a transabdominal approach. Transabdominal accuracy can...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Parenchymal-sparing hepatectomy for multiple bilobar colorectal liver metastases in a Jehovah’s witness: a case report

Ratnayake S, Subasinghe D, Dassanayake V, Sivaganesh S

Parenchymal-sparing hepatectomy (PSH), though technically challenging, is emerging as a choice of treatment for colorectal liver metastases (CRLM). PSH in Jehovah’s witness (JW) patients, for whom transfusion is not an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-alcoholic fatty liver disease-related hepatocellular carcinoma

Daher D, Dahan KSE, Singal AG

Non-alcoholic fatty liver disease (NAFLD), one of the most common causes of liver disease, is an increasingly common cause of hepatocellular carcinoma (HCC). Several demographic, clinical, and genetic factors contribute...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus

Cho Y, Park HS, Huh BW, Lee Yh, Seo SH, Seo DH, Ahn SH, Hong S, Kim SH

Background: We aimed to evaluate whether non-alcoholic fatty liver disease (NAFLD) with or without sarcopenia is associated with progression of carotid atherosclerosis in patients with type 2 diabetes mellitus (T2DM). Methods:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study

Kim KS, Hong S, Ahn HY, Park CY

Background: We investigated whether metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with an elevated risk of all-cause and cardiovascular mortality using a large-scale health examination cohort. Methods: A total of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy

Ozdogan E, Arikan C

Chronic liver disease incidence is increasing among children worldwide due to a multitude of epidemiological changes. Most of these chronic insults to the pediatric liver progress to fibrosis and cirrhosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Role of Endoscopic Ultrasound in Hepatology

Alqahtani SA, Ausloos F, Park JS, Jang S

Endoscopic ultrasound (EUS) has been an indispensable and widely used diagnostic tool in several medical fields, including gastroenterology, cardiology, and urology, due to its diverse therapeutic and diagnostic applications. Many...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease

Lee HA, Kim SU, Lim J, Kim MY, Kim SG, Suk KT, Jang JY, An H, Yim HJ, Seo YS

Background/Aims: We investigated the factors related to spleen length and the diagnostic accuracy of a model using spleen length corrected by related factors, for the prediction of varices needing treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary Hepatic Choriocarcinoma with Pregnancy: A Diagnostic and Therapeutic Challenge

Pakkala AK, Nekarakanti PK, Nagari B, Bansal AK, Shroff G, Uppin MS

Choriocarcinoma occurs mainly in the gonads, but an extragonadal origin has been reported, albeit infrequently. Primary hepatic choriocarcinoma (PHC) is a rare malignancy, with only 11 cases reported. Most cases...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis and Treatment of Primary Biliary Cholangitis

Kim KA

Primary biliary cholangitis (PBC) is an autoimmune disease prevalent in middle-aged women and characterized by chronic cholestasis. PBC is diagnosed when at least two of the following three criteria are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epidemiology of Autoimmune Liver Disease

Heo NY

Autoimmune liver disease is an important immune-mediated pathologic entity involving the liver and intrahepatic bile duct, including autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. Although it is necessary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical outcomes of gastric cancer surgery after liver transplantation

Kim S, Lee HJ, Alzahrani F, Kim J, Kim SH, Kim S, Cho YS, Park JH, Lee JM, Kong SH, Park DJ, Suh KS, Yang HK

Purpose: De novo malignancy is common after liver transplantation (LT); however, there are limited reports on the clinical outcomes of gastric cancer surgery after LT. Our study aimed to investigate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments

Ahn SB

Nonalcoholic fatty liver disease (NAFLD) affects approximately 30% of the population worldwide and includes nonalcoholic fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis. Since NAFLD-associated diseases begin with steatosis, the early...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nonalcoholic fatty liver disease and non-liver comorbidities

Manikat R, Nguyen MH

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by excess fat accumulation in the liver. It is closely associated with metabolic syndrome, and patients with NAFLD often...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management

Battistella S, D’Arcangelo F, Grasso M, Zanetto A, Gambato M, Germani G, Senzolo M, Russo FP, Burra P

Non-alcoholic fatty liver disease (NAFLD) is currently the fastest growing indication to liver transplantation (LT) in Western Countries, both for end stage liver disease and hepatocellular carcinoma. NAFLD/non-alcoholic steatohepatitis (NASH)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-alcoholic fatty liver disease: Definition and subtypes

Han SK, Baik SK, Kim MY

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide, with a global prevalence of approximately 30%. However, the prevalence of NAFLD has been variously reported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease

Oh H, Sohn W, Cho YK

Non-alcoholic fatty liver disease (NAFLD) is accepted as a counterpart to alcohol-related liver disease because it is defined as hepatic steatosis without excessive use of alcohol. However, the definition of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr